Displaying 13 - 24 of 30
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Immune-Mediated and Cholestatic Diseases
6

Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021

View
Metabolism, Alcohol & Toxicity
5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
5

International Medical Press: Obesity management in NAFLD/NASH: can we do more? - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View
Metabolism, Alcohol & Toxicity
4

Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020

View
Displaying 13 - 24 of 30